Therakos

The THERAKOS UVAR® XTS™ System is the most advanced and innovative technology used to treat cutaneous T-cell lymphoma (CTCL). The Fluid Logic Controller and Module, which is the heart of the System, was designed and continues to be manufactured by DEKA. It utilizes DEKA’s patented FMS Technology to measure, move, pump, and route fluid throughout the System.

THERAKOS is a Johnson & Johnson Company.